Incyte Posts Plummeting Q1 Revenues; Separates Information Business from Discovery | GenomeWeb

NEW YORK, May 5 - Incyte today reported first-quarter 2003 revenues of less than half that of the year-ago period, accompanied by widening losses. The company also said it is restructuring to separate its information business from its drug discovery activities.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.